Utah Medical Products UTMD Payments for Repurchase of Common Stock
Payments for Repurchase of Common Stock at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's payments for repurchase of common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Utah Medical Products's payments for repurchase of common stock?
- Utah Medical Products (UTMD) reported payments for repurchase of common stock of $128K in Q1 2026.
- How has Utah Medical Products's payments for repurchase of common stock changed year-over-year?
- Utah Medical Products's payments for repurchase of common stock decreased by 96.0% year-over-year, from $3.22M to $128K.
- What does payments for repurchase of common stock mean?
- Represents cash outflows used to buy back shares from the open market, effectively reducing the total share count. This is a key component of capital allocation strategy, often used to return value to shareholders and signal management confidence.